CIK 0001853921 · <br>Emerging growth company
Scribe Therapeutics, Inc.
Sign in to watch- Ticker
- SCTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822157847
- Phone
- 510-454-0213
- Business address
- 1150 MARINA VILLAGE PKWY, ALAMEDA, CA, 94501
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-23 | Parrot David Chief Financial Officer | Purchase | +1,333 | $15.00 | $20K | 1,333 |
| 2026-07-23 | Parrot David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +109,426 | 109,426 | ||
| 2026-07-23 | Parrot David Chief Financial Officer | Grant or award · Performance-based Stock Option (Right to Buy) | +109,426 | 109,426 | ||
| 2026-07-23 | Oakes Benjamin L. President, CEO | Grant or award · Stock Option (Right to Buy) | +264,784 | 264,784 | ||
| 2026-07-23 | Oakes Benjamin L. President, CEO | Grant or award · Performance-based Stock Option (Right to Buy) | +429,599 | 429,599 | ||
| 2026-07-23 | Bleharski Joshua Director | Grant or award · Stock Option (Right to Buy) | +14,725 | 14,725 | ||
| 2026-07-23 | Lucas Svetlana Chief Business Officer | Purchase | +3,000 | $15.00 | $45K | 3,000 |
| 2026-07-23 | Lucas Svetlana Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +109,426 | 109,426 | ||
| 2026-07-23 | Lucas Svetlana Chief Business Officer | Grant or award · Performance-based Stock Option (Right to Buy) | +109,426 | 109,426 | ||
| 2026-07-23 | GORDON CARL L Director | Grant or award · Stock Option (Right to Buy) | +14,725 | 14,725 | ||
| 2026-07-23 | Aghazadeh Behzad Director | Grant or award · Stock Option (Right to Buy) | +14,725 | 14,725 | ||
| 2026-03-13 | Staahl Brett 10% owner | Grant or award · Stock Option (Right to Buy) | +4,755 | 4,755 | ||
| 2026-03-13 | Parrot David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +8,909 | 8,909 | ||
| 2026-03-13 | Oakes Benjamin L. President, CEO | Grant or award · Stock Option (Right to Buy) | +12,969 | 12,969 | ||
| 2026-03-13 | Lucas Svetlana Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +9,547 | 9,547 |
Page 2 of 2 · 35 trades